跳至主要内容
临床试验/PACTR202103543569729
PACTR202103543569729已完成未知

Efficacy of perioperative bisoprolol and ivabradine versus bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting

Faculty of Medicine University of Alexandria0 个研究点目标入组 50 人开始时间: 2021年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients who will be scheduled for coronary artery bypass graft surgery (CABG).

排除标准

  • - Patients with atrial fibrillation or past history of atrial fibrillation.
  • - Concurrent valve surgery or valvular heart diseases (including moderate to severe mitral or aortic regurgitation or stenosis).
  • - Preoperative heart rate of < 50 beats/minute, 2nd or 3rd degrees AV block.
  • - Prior coronary artery bypass graft.
  • - Abnormal renal function with creatinine level (>2mg/dl), end stage renal disease (ESRD) on maintenance dialysis.
  • - Patients on chronic amiodarone or digoxin therapy.
  • - Poor left ventricular function (Ejection fraction < 35 %).
  • - Emergency operation.

研究者

相似试验

已完成
4 期
Effect of Short&#45;term Bisoprolol on Perioperative Myocardial Injury in Patient Undergoing Non&#45;cardiac SurgeryThe patient who undergo abdominal aortic surgeryThe patient who undergo infrainguinal arterial reconstruction surgeryThe patient who undergo non&#45cardiac thoracic surgeryBisoprololPerioperative Myocardial InjuryNon&#45cardiac Surgery
TCTR20180329005The Thailand Research Fund116
进行中(未招募)
1 期
Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathyon-obstructive hypertrophic cardiomyopathy
CTIS2024-515346-17-00Aarhus Universitetshospital140
进行中(未招募)
1 期
The effect of Bisoprolol and Verapamil in non-obstructive hypertrophic cardiomyopathyon-obstructive Hypertrophic cardiomyopathyMedDRA version: 20.0Level: PTClassification code 10007636Term: CardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10049813Term: Non-obstructive cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 27.0Level: PTClassification code 10020871Term: Hypertrophic cardiomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10061029Term: Cardiomyopathy primarySystem Organ Class: 10007541 - Cardiac disorders
EUCTR2021-006953-77-DKAarhus University Hospital140
已完成
2 期
Evaluation of preventive effect of bisoprolol in sub clinical Heart failure
IRCT20240609062050N1Iran University of Medical Sciences70
已完成
3 期
Evaluation of the effect of bisoprolol in the control of atrial fibrillatioAtrial fibrillation in patients undergoing coronary artery bypass grafting.Atrial fibrillation and flutter
IRCT20210121050095N1Qazvin University of Medical Sciences114